A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo

J Glauer(University of Göttingen), Michael P. Schön(University of Würzburg)
Blood Cancer Journal
September 6, 2013
Cited by 26


Related Papers